Wiskott-Aldrich Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Two point mutations together in the proline rich region (PRR) domain of WASP (S339Y/P373S) have been reported to cause WAS however the molecular defect has not been characterized.
|
24440360 |
2014 |
Wiskott-Aldrich Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
Mutations in the gene encoding the Wiskott-Aldrich syndrome protein (WASP) are responsible for Wiskott-Aldrich syndrome and WASP is a major actin regulator in the cytoplasm.
|
24402308 |
2014 |
Wiskott-Aldrich Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
[Mutation analysis of WASP gene and prenatal diagnosis of Wiskott-Aldrich syndrome].
|
25476427 |
2014 |
Wiskott-Aldrich Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The majority of missense mutations causing WAS and XLT are found in the WH1 (WASP Homology) domain of WASP, known to mediate interaction with WIP (WASP Interacting Protein) and CIB1 (Calcium and Integrin Binding).
|
25200405 |
2014 |
Wiskott-Aldrich Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
In conclusion, our findings demonstrate that WASp-deficiency perturbs B-cell homeostasis thus adding a new layer of immune dysregulation concurring to the increased susceptibility to develop autoimmunity in WAS patients.
|
24369837 |
2014 |
Wiskott-Aldrich Syndrome
|
1.000 |
AlteredExpression
|
disease |
BEFREE |
All phenotypic alterations observed in K562WASKO cells were alleviated upon expression of WAS following lentiviral transduction, confirming the role of WASP in these phenotypes.
|
23324327 |
2013 |
Wiskott-Aldrich Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Clinical and molecular characterization of Thai patients with Wiskott-Aldrich syndrome.
|
23033889 |
2013 |
Wiskott-Aldrich Syndrome
|
1.000 |
Biomarker
|
disease |
CLINGEN |
Modelling of human Wiskott-Aldrich syndrome protein mutants in zebrafish larvae using in vivo live imaging.
|
23868979 |
2013 |
Wiskott-Aldrich Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The Wiskott-Aldrich syndrome (WAS) is an X-linked recessive disorder characterized by thrombocytopenia, eczema and various degrees of immune deficiency caused by mutations in the WAS gene, which encodes the WASP protein, the expression of which is restricted to haematopoietic cells.
|
23689198 |
2013 |
Wiskott-Aldrich Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Wiskott-Aldrich syndrome (WAS) is an inherited immunodeficiency caused by mutations in the gene encoding WASP, a protein regulating the cytoskeleton.
|
23845947 |
2013 |
Wiskott-Aldrich Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
Viral clearance and associated immunopathology were measured after infection of WASP-deficient (WAS KO) mice with lymphocytic choriomeningitis virus (LCMV).
|
23141740 |
2013 |
Wiskott-Aldrich Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Non-haematological features, such as eczema (n = 7) and bloody stools (n = 6), ultimately led to the diagnosis of WAS at a median age of 4 months (range, 3-8 months), which was confirmed by absent (n = 6) or reduced (n = 1) WASP expression in lymphocytes by flow cytometry (FCM) and a WASP gene mutation.
|
23023736 |
2013 |
Wiskott-Aldrich Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
We describe the development of a self-inactivating lentiviral vector containing chromatin insulators for treatment of WAS and compare a gammaretroviral (MND), human cellular (EF1α), and the human WASp gene promoter for expression patterns in vivo during murine hematopoiesis using the green fluorescent protein (GFP) marker.
|
23786330 |
2013 |
Wiskott-Aldrich Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Wiskott-Aldrich syndrome (WAS) is a life-threatening X-linked recessive immunodeficiency disease described as a clinical triad of thrombocytopenia, eczema, and recurrent infections, caused by mutations of the WAS protein (WASP) gene.
|
23264413 |
2012 |
Wiskott-Aldrich Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome.
|
22426750 |
2012 |
Wiskott-Aldrich Syndrome
|
1.000 |
Biomarker
|
disease |
MGD |
Development of IgA nephropathy-like glomerulonephritis associated with Wiskott-Aldrich syndrome protein deficiency.
|
22079330 |
2012 |
Wiskott-Aldrich Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Molecular basis of Wiskott-Aldrich syndrome in patients from India.
|
22679904 |
2012 |
Wiskott-Aldrich Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Clinical profile and genetic basis of Wiskott-Aldrich syndrome at Chandigarh, North India.
|
22523910 |
2012 |
Wiskott-Aldrich Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
The Wiskott-Aldrich syndrome (WAS) is an X-linked disorder characterized by eczema, thrombocytopenia and immunodeficiency.
|
22215016 |
2012 |
Wiskott-Aldrich Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
A female offspring of consanguineous parents, showed features of Wiskott-Aldrich syndrome (WAS), including recurrent infections, eczema, thrombocytopenia, defective T cell proliferation and chemotaxis, and impaired natural killer cell function.
|
22231303 |
2012 |
Wiskott-Aldrich Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Clinical characteristics and molecular analysis of three Chinese children with Omenn syndrome.
|
21771083 |
2011 |
Wiskott-Aldrich Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Genetic characteristics of eighty-seven patients with the Wiskott-Aldrich syndrome.
|
21185603 |
2011 |
Wiskott-Aldrich Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Wiskott-Aldrich syndrome mutation in two Turkish siblings with X-linked thrombocytopenia.
|
27264129 |
2011 |
Wiskott-Aldrich Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
The WASP gene was sequenced from genomic DNA of patients with WAS, as well as their family members to identify carriers.
|
21185603 |
2011 |
Wiskott-Aldrich Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Clinical manifestations, immunologic functions, and WASP gene sequencing and expressions were analyzed in WAS patients.
|
20232122 |
2010 |